Hunan Jiudian Pharmaceutical Co Ltd Tangible Net Worth Ratio
Hunan Jiudian Pharmaceutical Co Ltd tangible net worth ratio. Hunan Jiudian Pharmaceutical Co Ltd (300705) has a Tangible Net Worth Ratio of 76.0% as of June 2026. This metric is calculated by deducting intangible assets (CN¥658.27 Million) from net assets (CN¥2.75 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Hunan Jiudian Pharmaceutical Co Ltd (300705) net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Hunan Jiudian Pharmaceutical Co Ltd (2013–2025)
Tangible net worth ratio of Hunan Jiudian Pharmaceutical Co Ltd from 2013 to 2025. This chart shows how Hunan Jiudian Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 13 annual periods from 2013 to 2025. As of June 2026, the ratio stands at 76.0%, reflecting net assets of CN¥2.75 Billion with intangible assets of CN¥658.27 Million CNY. Check 300705 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Hunan Jiudian Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (2013–2025)
Hunan Jiudian Pharmaceutical Co Ltd tangible net worth ratio by year from 2013 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Hunan Jiudian Pharmaceutical Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 300705 market cap.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 78.6% | CN¥2.79 Billion | CN¥595.36 Million | CN¥4.02 Billion | ▼ -15.4 pp |
| 2024 | 94.1% | CN¥2.53 Billion | CN¥150.11 Million | CN¥3.37 Billion | ▼ -0.3 pp |
| 2023 | 94.3% | CN¥1.97 Billion | CN¥112.23 Million | CN¥2.87 Billion | ▲ +0.8 pp |
| 2022 | 93.5% | CN¥1.55 Billion | CN¥100.27 Million | CN¥2.30 Billion | ▲ +0.6 pp |
| 2021 | 93.0% | CN¥1.10 Billion | CN¥77.36 Million | CN¥1.75 Billion | ▼ -0.9 pp |
| 2020 | 93.9% | CN¥835.68 Million | CN¥51.06 Million | CN¥1.13 Billion | ▲ +0.7 pp |
| 2019 | 93.2% | CN¥761.87 Million | CN¥52.14 Million | CN¥1.07 Billion | ▲ +0.5 pp |
| 2018 | 92.6% | CN¥718.16 Million | CN¥52.87 Million | CN¥943.21 Million | ▲ +0.5 pp |
| 2017 | 92.1% | CN¥660.26 Million | CN¥52.04 Million | CN¥769.20 Million | ▼ -2.5 pp |
| 2016 | 94.6% | CN¥323.43 Million | CN¥17.44 Million | CN¥397.03 Million | ▲ +2.3 pp |
| 2015 | 92.3% | CN¥254.51 Million | CN¥19.69 Million | CN¥318.32 Million | ▲ +2.6 pp |
| 2014 | 89.7% | CN¥209.87 Million | CN¥21.61 Million | CN¥268.57 Million | ▲ +3.3 pp |
| 2013 | 86.4% | CN¥175.85 Million | CN¥23.99 Million | CN¥252.15 Million | — |